{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:25Z","timestamp":1792664665338,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We report a case of progressive, severe mpox virus (MPXV) infection in a patient with AIDS despite a standard course of tecovirimat. He significantly improved after administration of vaccinia immune globulin intravenous (VIGIV) highlighting its use as an adjunct for severe disease in immunocompromised hosts.<\/jats:p>","DOI":"10.1093\/cid\/ciac971","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T11:51:43Z","timestamp":1672055503000},"page":"1671-1673","source":"Crossref","is-referenced-by-count":44,"title":["The <scp>u<\/scp>se of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus\/AIDS"],"prefix":"10.1093","volume":"76","author":[{"given":"Andrea K","family":"Thet","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Kelly","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabirah N","family":"Kasule","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish K","family":"Shah","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency, Department of Internal Medicine, BronxCare Health System affiliated with Icahn School of Medicine at Mt Sinai , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Chawala","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency, Department of Internal Medicine, BronxCare Health System affiliated with Icahn School of Medicine at Mt Sinai , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Latif","sequence":"additional","affiliation":[{"name":"Department of Medicine, American University of the Caribbean School of Medicine , Cupecoy, St Marteen , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar S","family":"Chilimuri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, BronxCare Health System , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmina B","family":"Zeana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System , Bronx, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"2023050318401862100_ciac971-B1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"Magnus","year":"1959","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2023050318401862100_ciac971-B2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.add4153","article-title":"Multiple lineages of monkeypox virus detected in the United States 2021\u20132022","volume":"378","author":"Gigante","year":"2022","journal-title":"Science"},{"key":"2023050318401862100_ciac971-B3","author":"Centers for Disease Control and Prevention"},{"key":"2023050318401862100_ciac971-B4","author":"Centers for Disease Control and Prevention"},{"key":"2023050318401862100_ciac971-B5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4269\/ajtmh.20-0589","article-title":"A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the democratic Republic of Congo","volume":"104","author":"Hughes","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2023050318401862100_ciac971-B6","author":"FDA"},{"key":"2023050318401862100_ciac971-B7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp2210125","article-title":"Tecovirimat and the treatment of monkeypox\u2014past, present, and future considerations","volume":"387","author":"Sherwat","year":"2022","journal-title":"N Engl J Med"},{"key":"2023050318401862100_ciac971-B8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"2023050318401862100_ciac971-B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2022.10.031","article-title":"A severe monkeypox infection on a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome","volume":"125","author":"Vigeur","year":"2002","journal-title":"Int J Infect Dis"},{"key":"2023050318401862100_ciac971-B10","author":"FDA"},{"key":"2023050318401862100_ciac971-B11","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/AAC.49.7.2634-2641.2005","article-title":"Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection","volume":"49","author":"Shearer","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2023050318401862100_ciac971-B12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/v14091960","article-title":"Vaccinia-virus-based vaccines are expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus","volume":"14","author":"Ahmed","year":"2022","journal-title":"Viruses"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac971\/48624991\/ciac971.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/9\/1671\/50189437\/ciac971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/9\/1671\/50189437\/ciac971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T18:43:02Z","timestamp":1683139382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/9\/1671\/6960883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,12,26]]},"published-print":{"date-parts":[[2023,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac971","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,12,26]]}}}